24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
45.65% |
|
CANCER |
32.61% |
|
ENZYME DYNAMICS |
21.74% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
49.18% |
|
PEPTIDOMIMETIC CD40L BINDING |
46.2% |
|
ENZYME DYNAMICS |
2.72% |
|
ATSTP10 TRANSPORT SIMULATION |
1.9% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
33.79% |
|
CANCER |
24.73% |
|
PEPTIDOMIMETIC CD40L BINDING |
17.73% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
15.86% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
3.62% |
|
ALZHEIMERS |
2.32% |
|
ATSTP10 TRANSPORT SIMULATION |
.85% |
|
MEMBRANE TRANSPORT |
.45% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.28% |
|
ATSTP10 SUCROSE TRANSPORT |
.28% |
|
NIPAH VIRUS DECOY PROTEINS |
.08% |